DMPHF Dividend: Dermapharm Holding SE Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

DMPHF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,160	1,180	1,135	1,024	942	793
Revenue Growth (YoY)	0%	4%	11%	9%	19%	13%
Cost of Revenue	387	413	416	363	322	330
Gross Profit	772	767	719	660	620	463
Selling, General & Admin	289	424	418	290	257	257
Research & Development	--	11	10	13	14	12
Operating Expenses	555	539	518	377	325	320
Other Non Operating Income (Expenses)	--	-4	-3	-1	0	-1
Pretax Income	171	172	105	216	292	125
Income Tax Expense	57	60	45	83	84	39
Net Income	116	113	62	134	209	85
Net Income Growth	28.99%	82%	-54%	-36%	146%	10%
Shares Outstanding (Diluted)	54.38	53.84	53.84	53.84	53.84	53.84
Shares Change (YoY)	1%	0%	0%	0%	0%	0%
EPS (Diluted)	2.15	2.11	1.15	2.49	3.89	1.59
EPS Growth	28%	82%	-54%	-36%	144%	11%
Free Cash Flow	164	163	177	249	189	91
Free Cash Flow Per Share	3.01	3.02	3.28	4.62	3.51	1.69
Gross Margin	66.55%	65%	63.34%	64.45%	65.81%	58.38%
Operating Margin	18.62%	19.23%	17.62%	27.63%	31.31%	17.9%
Profit Margin	10%	9.57%	5.46%	13.08%	22.18%	10.71%
Free Cash Flow Margin	14.13%	13.81%	15.59%	24.31%	20.06%	11.47%
EBITDA	303	305	285	334	340	185
EBITDA Margin	26.12%	25.84%	25.11%	32.61%	36.09%	23.32%
D&A For EBITDA	87	78	85	51	45	43
EBIT	216	227	200	283	295	142
EBIT Margin	18.62%	19.23%	17.62%	27.63%	31.31%	17.9%
Effective Tax Rate	33.33%	34.88%	42.85%	38.42%	28.76%	31.2%